ストックスクリーナーアプリを入手
2.67
3.96%
-0.11
アフターアワーズ：
2.67
前日終値:
$2.78
開ける：
$2.7
24時間の取引高:
111.80K
Relative Volume:
0.50
時価総額：
$93.48M
収益：
-
当期純損益:
$-32.94M
株価収益率:
-2.4054
EPS:
-1.11
ネットキャッシュフロー:
$-24.95M
1週間 パフォーマンス:
-10.10%
1か月 パフォーマンス:
-13.03%
6か月 パフォーマンス:
-43.67%
1年 パフォーマンス:
-41.25%
1日の値動き範囲:
$2.655
$2.80
1週間の範囲:
$2.655
$2.99
52週間の値動き範囲:
$2.51
$5.59
Achieve Life Sciences Inc Stock (ACHV) Company Profile
名前
Achieve Life Sciences Inc
セクター
電話
425-686-1500
住所
22722 29TH DR. SE, SEATTLE, BC
ACHV を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
ACHV
Achieve Life Sciences Inc
|
2.67 | 93.48M | 0 | -32.94M | -24.95M | -1.11 |
|
VRTX
Vertex Pharmaceuticals Inc
|
484.82 | 131.41B | 11.02B | -535.60M | -978.00M | -2.20 |
|
REGN
Regeneron Pharmaceuticals Inc
|
634.23 | 72.26B | 14.20B | 4.41B | 3.54B | 38.28 |
|
ARGX
Argen X Se Adr
|
591.87 | 36.10B | 2.19B | 833.04M | -1.28B | 12.71 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
270.02 | 35.03B | 2.25B | -278.16M | -42.59M | -2.17 |
|
ONC
Beigene Ltd Adr
|
272.17 | 28.24B | 3.81B | -644.79M | -669.77M | -6.24 |
Achieve Life Sciences Inc Stock (ACHV) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2024-11-14 | 開始されました | Rodman & Renshaw | Buy |
| 2024-09-27 | 開始されました | Raymond James | Strong Buy |
| 2023-05-10 | 繰り返されました | Maxim Group | Buy |
| 2021-06-23 | 開始されました | Oppenheimer | Outperform |
Achieve Life Sciences Inc (ACHV) 最新ニュース
Contrasting Achieve Life Sciences (NASDAQ:ACHV) & Oruka Therapeutics (NASDAQ:ORKA) - Defense World
Achieve Life Sciences, Inc. (NASDAQ:ACHV) CFO Purchases $28,900.00 in Stock - MarketBeat
Insider Buying: Mark Oki Acquires Shares of Achieve Life Sciences Inc (ACHV) - GuruFocus
Achieve Life Sciences, Inc. (ACHV): A Bull Case Theory - MSN
Achieve Life Sciences CEO Richard Stewart purchases $28,598 in stock - Investing.com India
Achieve Life Sciences CFO Mark Oki buys $28,887 in stock - Investing.com India
Achieve Life Sciences (ACHV) Expected to Announce Quarterly Earnings on Thursday - Defense World
Achieve Life Sciences Executives Acquire Shares - TradingView
Achieve Life Sciences CFO Mark Oki buys $28,887 in stock By Investing.com - Investing.com UK
Achieve Life Sciences CEO Richard Stewart purchases $28,598 in stock By Investing.com - Investing.com UK
Achieve Life Sciences: Promising Clinical Progress and Strategic Leadership Enhancements Justify Buy Rating - TipRanks
ACHV stock touches 52-week low at $2.81 amid market challenges - Investing.com India
Achieve Life Sciences (NASDAQ:ACHV) Announces Earnings Results - MarketBeat
Achieve Life Sciences, Inc. (NASDAQ:ACHV) Q4 2024 Earnings Call Transcript - Insider Monkey
ACHV: 2Q:25 NDA Submission - Yahoo Finance
Achieve Life Sciences Inc (ACHV) Q4 2024 Earnings Call Highlights: Strategic Advances Amid ... - Yahoo
Achieve Life Sciences Reports 2024 Financial Results - TipRanks
Achieve Life Sciences misses Q4 earnings, shares fall By Investing.com - Investing.com South Africa
Achieve Life Sciences misses Q4 earnings, shares fall - Investing.com
Earnings call transcript: Achieve Life Sciences Q4 2024 sees slight EPS miss By Investing.com - Investing.com South Africa
Earnings call transcript: Achieve Life Sciences Q4 2024 sees slight EPS miss - Investing.com
Achieve Life Sciences Q4 Loss Widens - Nasdaq
Achieve Life Sciences Inc reports results for the quarter ended December 31Earnings Summary - TradingView
Achieve Life Sciences Reports Financial Results for Fourth Quarter and Year-End 2024 and Provides Update on the Cytisinicline Development Program - The Manila Times
ACHIEVE LIFE SCIENCES Earnings Results: $ACHV Reports Quarterly Earnings - Nasdaq
ACHIEVE LIFE SCIENCES, INC. SEC 10-K Report - TradingView
Achieve Life Sciences Announces Planned NDA Submission for Cytisinicline Targeting End of Q2 2025 - Nasdaq
Achieve Life Sciences Reports Financial Results for Fourth - GlobeNewswire
Achieve Life Sciences Hits Major FDA Milestone as Q4 Results Show $34.4M Cash Position - StockTitan
Earnings Scheduled For March 11, 2025 - Benzinga
SBI Securities Co. Ltd. Purchases New Shares in Achieve Life Sciences, Inc. (NASDAQ:ACHV) - Defense World
Achieve Life Sciences (ACHV) Projected to Post Earnings on Tuesday - Defense World
Can This Smoking Cessation Drug Developer Disrupt a $20B Market? Key Presentation Coming - StockTitan
Achieve Life Sciences to Present at the Barclays 27th Annual Global Healthcare Conference - The Manila Times
Achieve Life Sciences Inc expected to post a loss of 32 cents a shareEarnings Preview - TradingView
Achieve Life Sciences to Announce Fourth Quarter and Year-End 2024 Financial Results and Host Conference Call and Webcast on March 11, 2025 - The Manila Times
INVESTVIEW, INC. ANNOUNCES LAUNCH OF STOCK REPURCHASE PROGRAM - The Manila Times
Achieve Life Sciences to Report Fourth Quarter and Year-End 2024 Financial Results and Cytisinicline Development Update - Nasdaq
Achieve Life Sciences to Announce Fourth Quarter and - GlobeNewswire
Can This Smoking Cessation Drug Developer Turn 2024 Results Into 2025 Success? - Stock Titan
ACHV Stock Touches 52-Week Low at $2.83 Amid Market Challenges - Investing.com Australia
Qualia Supplements Achieve Multiple Finalist Honors For Product Excellence At 2025 NEXTY Awards - Yahoo Finance
ACHV Stock Touches 52-Week Low at $2.83 Amid Market Challenges By Investing.com - Investing.com South Africa
Achieve Life Sciences, Inc. to Host Earnings Call - ACCESS Newswire
Achieve Life Sciences to Participate in Two Upcoming Investor Conferences - ACCESS Newswire
Veradigm Becomes First EHR Media Platform to Achieve POCMA Certification - Business Wire
CBD Life Sciences Inc. (CBDL) Launches Mushroom Powder Capsules - ACCESS Newswire
Technology | Definition, Examples, Types, & Facts - Britannica
Artificial Intelligence (AI) in Life Sciences Market Size to Worth USD 13.89 Bn by 2034 - BioSpace
Here are Rogue Funds Updates on Achieve Life Sciences (ACHV) - Insider Monkey
Achieve Life Sciences, Inc. (NASDAQ:ACHV) Sees Significant Drop in Short Interest - MarketBeat
Achieve Life Sciences Inc (ACHV) 財務データ
収益
当期純利益
現金流量
EPS
1.05%
1.79%
大文字化:
|
ボリューム (24 時間):